Lane 1: Raji cell lysate
Lane 2: Hela cell lysate
Lane 3: HepG2 cell lysate
Lane 4: MCF-7 cell lysate
Recombinant Rabbit monoclonal primary
CD86 Recombinant Rabbit Monoclonal Antibody [SJ20-00] (ET1606-50)
Synthetic peptide within human cd86 aa 1-50 / 329.
Hela, HUVEC, JAR, human tonsil tissue, K562, Raji.
Store at +4C after thawing. Aliquot store at -20C or -80C. Avoid repeated freeze / thaw cycles.
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Protein A affinity purified.
Activation B7-2 antigen 3 antibody; Activation B7-2 antigen antibody; B-lymphocyte activation antigen B7-2 2 antibody; B-lymphocyte activation antigen B7-2 antibody; B7 2 antibody; B7 antibody; B7-2 antibody; B7.2 antibody; B70 antibody; B72 antigen antibody; BU63 antibody; CD28 antigen ligand 2 2 antibody; CD28 antigen ligand 2 antibody; Cd28l2 antibody; CD28LG2 antibody; CD86 antibody; CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) 1, 2 antibody; CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) antibody; CD86 antigen antibody; CD86 molecule antibody; CD86_HUMAN antibody; CLS1 antibody; CTLA-4 counter-receptor B7.2 2, 3 antibody; CTLA-4 counter-receptor B7.2 antibody; Early T-cell costimulatory molecule 1 antibody; ETC-1 antibody; FUN 1 antibody; FUN-1 antibody; LAB72 antibody; Ly-58 antibody; Ly58 antibody; MB7 antibody; MB7-2 antibody; Membrane glycoprotein antibody; MGC34413 antibody; T-lymphocyte activation antigen CD86 antibody; TS/A-2 antibody
Expressed by activated B-lymphocytes and monocytes.
Polyubiquitinated; which is promoted by MARCH8 and results in endocytosis and lysosomal degradation.
T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins B7-1 (CD80) and B7-2 (CD86) expressed on antigen presenting cells bind the homologous T cell receptors CD28 and CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28, and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counterreceptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.